216 related articles for article (PubMed ID: 23890144)
41. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
[TBL] [Abstract][Full Text] [Related]
42. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas.
Sawhney MS; Al-Bashir S; Cury MS; Brown A; Chuttani R; Pleskow DK; Callery MP; Vollmer CM
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1373-6. PubMed ID: 19577006
[TBL] [Abstract][Full Text] [Related]
43. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
[TBL] [Abstract][Full Text] [Related]
44. Overview of the investigation and management of cystic neoplasms of the pancreas.
Spence RA; Dasari B; Love M; Kelly B; Taylor M
Dig Surg; 2011; 28(5-6):386-97. PubMed ID: 22179508
[TBL] [Abstract][Full Text] [Related]
45. Magnetic resonance imaging in the assessment of cystic pancreatic lesions: differentiation of benign and malignant lesion status.
Lopez Hänninen E; Pech M; Ricke J; Denecke T; Amthauer H; Lehmkuhl L; Böhmig M; Röttgen R; Pinkernelle J; Felix R; Langrehr J
Acta Radiol; 2006 Mar; 47(2):121-9. PubMed ID: 16604957
[TBL] [Abstract][Full Text] [Related]
46. Endoscopic ultrasound identifies synchronous pancreas cystic lesions not seen on initial cross-sectional imaging.
Adimoolam V; Sanchez MJ; Siddiqui UD; Yu S; Dzuira JD; Padda MS; Aslanian HR
Pancreas; 2011 Oct; 40(7):1070-2. PubMed ID: 21705942
[TBL] [Abstract][Full Text] [Related]
47. [The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].
Voth M; Opfermann T; Gottschild D
Zentralbl Chir; 2003 May; 128(5):375-8. PubMed ID: 12813634
[TBL] [Abstract][Full Text] [Related]
48. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
49. Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions: 2017 Consensus Recommendations of the Korean Society of Abdominal Radiology.
Lee ES; Kim JH; Yu MH; Choi SY; Kang HJ; Park HJ; Park YS; Byun JH; Shin SS; Lee CH;
Korean J Radiol; 2019 Apr; 20(4):542-557. PubMed ID: 30887737
[TBL] [Abstract][Full Text] [Related]
50. The diagnostic role of CT, MRI/MRCP, PET/CT, EUS and DWI in the differentiation of benign and malignant IPMN: A meta-analysis.
Liu H; Cui Y; Shao J; Shao Z; Su F; Li Y
Clin Imaging; 2021 Apr; 72():183-193. PubMed ID: 33321460
[TBL] [Abstract][Full Text] [Related]
51. [Is accurate preoperative assessment of pancreatic cystic lesions possible?].
Záruba P; Dvořáková T; Závada F; Bělina F; Ryska M
Rozhl Chir; 2013 Dec; 92(12):708-14. PubMed ID: 24479516
[TBL] [Abstract][Full Text] [Related]
52. Cystsic lesions of the pancreas.
Mohamadnejad M; Eloubeidi MA
Arch Iran Med; 2013 Apr; 16(4):233-9. PubMed ID: 23496368
[TBL] [Abstract][Full Text] [Related]
53. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
[TBL] [Abstract][Full Text] [Related]
54. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P
Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955
[TBL] [Abstract][Full Text] [Related]
55. Characterization of cystic pancreatic masses: relative accuracy of CT and MRI.
Visser BC; Yeh BM; Qayyum A; Way LW; McCulloch CE; Coakley FV
AJR Am J Roentgenol; 2007 Sep; 189(3):648-56. PubMed ID: 17715113
[TBL] [Abstract][Full Text] [Related]
56. Accuracy of endoscopic ultrasound-guided fine needle aspiration cytology on the differentiation of malignant and benign pancreatic cystic lesions: a single-center experience.
Oguz D; Öztaş E; Kalkan IH; Tayfur O; Cicek B; Aydog G; Kurt M; Beyazit Y; Etik D; Nadir I; Sahin B
J Dig Dis; 2013 Mar; 14(3):132-9. PubMed ID: 23167591
[TBL] [Abstract][Full Text] [Related]
57. Advances in imaging for pancreatic disease.
Del Frate C; Zanardi R; Mortele K; Ros PR
Curr Gastroenterol Rep; 2002 Apr; 4(2):140-8. PubMed ID: 11900679
[TBL] [Abstract][Full Text] [Related]
58. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
59. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.
Mansour JC; Schwartz L; Pandit-Taskar N; D'Angelica M; Fong Y; Larson SM; Brennan MF; Allen PJ
J Gastrointest Surg; 2006 Dec; 10(10):1354-60. PubMed ID: 17175454
[TBL] [Abstract][Full Text] [Related]
60. 'Peripheric' pancreatic cysts: performance of CT scan, MRI and endoscopy according to final pathological examination.
Duconseil P; Turrini O; Ewald J; Soussan J; Sarran A; Gasmi M; Moutardier V; Delpero JR
HPB (Oxford); 2015 Jun; 17(6):485-9. PubMed ID: 25691074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
